You have read all your free articles, to continue reading subscribe to read the rest of this content.
OxThera announces the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer. Dehmel joins OxThera after serving as Executive Medical Director and Global Development Leader for Amgen's calcimimetic franchise. He has extensive experience in the life science sector, having led MedAlready a subscriber Login You have read all your free articles, to…
The company has announced the appointment of Christophe Bourdon as new Chief Executive Officer, effective April 1, 2022. Christophe Bourdon joins from Orphazyme A/S where he has held the position as CEO since April 2021, following global leadership roles in both Amgen and Alexion. Read more: LAlready a subscriber Login…
Valo Therapeutics has announced four appointments to its Scientific Advisory Board (SAB), Professor Paolo A. Ascierto, Dr Jeffery Bockman, Professor Malcolm K. Brenner, and Professor Kevin Harrington. “We are delighted to welcome our distinguished, and expert, new SAB members. They bring a wealAlready a subscriber Login You have read all…
Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel Dulac has 25 years of experience in the pharmaceutical industry, with a strong record of commercial and operational leadership underpinned by several senior roles in Europe and North America, reportAlready a subscriber Login You…
